RC48-ADC Combined With Bevacizumab in HER2-positive Advanced Colorectal Cancer

NCT05785325 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: RC48-ADC plus Bevacizumab

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University